Strelitz Diabetes Center Clinical Trials

Reducing diabetes distress in Adults with newly diagnosed Type 2 Diabetes:
A Pilot Study

Primary Investigator: Dr. Chinelo, Okigbo, MD

Sponsor: EVMS

Summary: To study the efficacy of a virtual health coaching intervention VS. standard of care on reducing diabetes distress in newly Dx diabetics.

Point of contact: 

• Abby McMillan | McMillAM@EVMS.edu (or odu.edu) | 757-446-5161

Start date: N/A. Currently recruiting and enrolling participants.

Eligibility: You may be eligible to participate in this study if you:

• Have Type 2 Diabetes diagnosis within the last 12 months.
• Have access to a mobile device, tablet, desktop for virtual education and/or health coaching.
• Registered patient of EVMS.

FINE-One: A Parallel-Group, Randomized, Prospective, Interventional, Double-Blind, Multicenter Global Phase 3 Study To Investigate The Efficacy And Safety Of Finerenone Versus Placebo, In Addition To Standard Of Care, In Participants With Chronic Kidney Disease And Type 1 Diabetes

Primary Investigator: Dr. Elias Siraj, MD

Sponsor: Bayer

Summary: The purpose of this study is to look at the efficacy and safety of the investigational drug, Finerenone versus a placebo (in addition to standard of care) in participants with chronic kidney disease and type 1 diabetes. 

Point of contact: 

• Anna Stoiber, MPH, BSN, RN | StoibeAM@EVMS.edu (or odu.edu) | 757-446-8477

Start date: N/A. Currently recruiting participants.

Eligibility: You may be eligible to participate in this study if you:

• Are 18 years or older.
• Have TYPE 1 diabetes.
• Have chronic kidney disease (CKD).
• Have a HbA1c less than 10%.

Primary Investigator:  Dr. Elias Siraj

Summary: To study the efficacy and safety of the current hard gelatin capsule formulation of NRD135S.E1 in the treatment of PDPN.

Sponsor: Harvard University and the NIH

Points of contact:

• Jordan Pettaway, MS | PettawJL@evms.edu (or odu.edu) | 757-446-7445

Start date: N/A. Currently recruiting and enrolling participants.

Eligibility: You may be eligible to participate in this study if you:

• Have a body mass index (BMI)  40 kg/m^2.
• Have Type 2 Diabetes.
• Have chronic DPNP.

Nutritional Lifestyle-based Study: Impact Of A Culturally Tailored, Personalized, Mobile Health-Based Lifestyle Intervention In Improving Metabolic Outcomes Of Overweight And Obese African Americans With Prediabetes In Underserved Communities Of Southeastern Virginia

Primary Investigator: Dr. Henri Parson, PhD

Sponsor: American Diabetes Association (ADA)

Summary: The purpose of this study is to identify effective and sustainable dietary lifestyle interventions for African American communities in Southeastern Virginia and to assess the efficacy of a culturally tailored mobile Health-based lifestyle intervention. The goal is to determine if a personal nutrition program can help you eat healthier without giving up your favorite flavors and your cultures' cuisines/cooking.

Point of contacts:

• Jan Patel | PatelJ1@evms.edu (or odu.edu) | 757-446-0577

Start date: 2024. Currently recruiting participants.

Eligibility: You may be eligible to participate in this study if you:

• Self identify as an African American
• Are 25-55 years old.
• Are diagnosed with Pre-diabetes and/or at risk for type 2 diabetes.
• Have a body mass index (BMI) between 25-40kg/m^2.